What Fluence does

Fluence operates an e-learning platform that delivers professional certificate programs in psychedelic-assisted therapy and integration for licensed mental health clinicians, alongside continuing education webinars and an introductory on-demand course for non-clinicians. The product architecture centers on a required 22-hour core curriculum, "Essentials of Psychedelic Therapy," that unlocks three specialty professional certificates covering Psychedelic Harm Reduction and Integration Therapy, Ketamine-Assisted Psychotherapy, and Psilocybin Facilitation, each carrying CE credits approved by the APA, ASWB, and NYSED. Fluence wraps the curriculum in proprietary infrastructure including a custom learning management system with role-based access and timestamped training tracking, a digital badging system, and the Psychedelic Therapist Directory, which functions as a marketplace connecting certified graduates with prospective clients and industry partners.

Fluence generates revenue through two distinct streams: individual clinician course sales (multi-year subscription pricing for the core and certificate programs, pay-as-you-go webinars and introductory content, and a 20% bundle discount) and B2B clinical trial training services sold to pharmaceutical and biotech drug developers. The B2B line includes protocol design consultation, treatment manual development, adherence criteria creation, multinational trial support, and the company's AI-powered training platform that uses generative AI to score role-play transcripts against custom rubrics and produce structured feedback. The AI capability is a key differentiator: it has been adopted by named drug developers including Reunion Neuroscience, Cybin, and Tryp Therapeutics, and is built on training data accumulated across over a dozen developer engagements, multiple compounds, and multilingual multinational trial contexts. The company also offers post-launch commercialization support covering clinician training, clinic staff training, and patient education materials.

The company is privately held, headquartered in the Bronx, New York, led by CEO and Co-Founder Elizabeth Nielson, PhD, and has trained over 8,000 therapists cumulatively. It has raised approximately $3 million across a November 2021 seed round ($1.6M from JLS Fund, Palo Santo, and Neo Kuma Ventures) and a February 2022 follow-on ($1.4M). Revenue is not publicly disclosed, but the combination of an 11-50 person headcount, a distributed individual learner base, and a small but growing enterprise B2B book places estimated annual revenue in the low single-digit millions. Strategic positioning centers on being the preeminent credentialing and training infrastructure for both the emerging psychedelic clinician workforce and the drug developers commercializing psychedelic-based treatments.

Name

Fluence

Legal name

Fluence International, Inc.

Website

https://fluencetraining.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Fluence is a New York-based e-learning platform that provides APA/ASWB/NYSED-accredited professional certificates in psychedelic-assisted therapy to licensed clinicians, plus AI-powered clinical trial training and consultation services to drug developers. The company has trained over 8,000 therapists and serves a global client base.

Ownership category

akta.pro rank

Product category

Professional Training and Continuing Education

NAICS

Professional and Management Development Training (61143)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Psychedelic therapy training
• Professional certificate programs
• Continuing education credits
• Clinical trial training
• Therapist directory platform

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Professional Certification Courses: Fluence offers professional certification programs in psychedelic therapy areas including Psychedelic Harm Reduction and Integration Therapy, Ketamine-Assisted Psychotherapy, and Psilocybin Facilitation. All programs include CE credits for psychologists, social workers, and mental health counselors as part of the base price.
2. B2B Clinical Trial Training Services: Consultation and custom training programs for drug developers including protocol design, treatment manual creation, adherence criteria development, and multinational trial support. Services include custom LMS, mobile apps, content libraries, and differentiated training tracks.
3. AI-Enabled Training Tools: AI-powered feedback tools for clinical trial training that analyze role-play transcripts and provide automated adherence scoring, offered to drug development partners.
4. Webinars and Continuing Education: Live-online webinars offering CE credits for clinicians, covering topics in psychedelic therapy, legislation, practice building, and specialized clinical applications.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Fluence operates a subscription-based e-learning platform that delivers APA/ASWB/NYSED-accredited continuing education and professional certificate programs in psychedelic therapy to licensed clinicians and psychotherapists, structured as a core Essentials course plus three specialty certificates. The company also generates enterprise revenue from drug developers through an AI-powered clinical trial training platform, custom Learning Management Systems, consultation for protocol design and adherence criteria, and post-launch commercialization services.

Product overview

Fluence is an e-learning education platform providing professional certificate programs in psychedelic therapy for licensed clinicians and healthcare professionals. The platform follows a two-tier curriculum structure: a required Core Curriculum (Essentials of Psychedelic Therapy) followed by three Professional Certificate programs (Psychedelic Harm Reduction and Integration Therapy, Ketamine-Assisted Psychotherapy, and Psilocybin Facilitation). Additional offerings include Introduction to Psychedelic Therapy for non-clinicians, webinars, and free educational content. For drug developers, Fluence offers B2B services including consultation on protocol design, AI-powered clinical trial training with automated feedback, and commercialization support. The platform also provides a Psychedelic Therapist Directory for certified graduates. All professional courses include APA-accredited continuing education credits.

Differentiator

Problem solved

Functional benefit

Products and services

• Essentials of Psychedelic Therapy 6-week foundational course providing 22 hours of APA-accredited CE credits covering the fundamentals of psychedelic therapy, required as a prerequisite for all Fluence Professional Certificate programs and intended for licensed clinicians.
• Psychedelic Harm Reduction and Integration Therapy Professional Certificate Specialty professional certificate program for licensed clinicians to gain expertise in harm reduction and integration therapy approaches for psychedelic-assisted treatments; includes CE credits.
• Ketamine-Assisted Psychotherapy Professional Certificate Specialty professional certificate program focused specifically on ketamine-assisted psychotherapy training for mental health clinicians; includes CE credits.
• Psilocybin Facilitation Professional Certificate Specialty professional certificate program for clinicians training to facilitate psilocybin-assisted therapy sessions; includes CE credits.
• Introduction to Psychedelic Therapy 12-hour on-demand introductory course covering molecule-specific education (MDMA, Psilocybin, Ketamine), harm reduction practices, and the fundamentals of psychedelic therapy, designed for non-clinicians seeking personal-interest or general-knowledge training.
• Live-Online Webinars with CE Credits Live-online webinar series covering psychedelic therapy topics, legislative updates, drug development insights, practice building, and specialized clinical applications, offering 1 CE hour per webinar for clinicians attending live.
• Psychedelic Therapist Directory Verified directory listing service that enables Fluence-certified therapists to be discoverable by clients and industry leaders; displays verifiable digital badges for completed Professional Certificates.
• AI-Powered Clinical Trial Training Platform B2B enterprise training platform for drug developers that uses AI-powered transcript analysis to deliver automated adherence feedback on trainee role-play practice sessions, including a custom Learning Management System with role-based access, mobile app access, and timestamped training tracking for clinical trial staff.
• Consultation for Drug Development Clinical research consultation services for drug developers including protocol design, psychedelic treatment manual development, adherence criteria generation, and multinational trial support, delivered by licensed clinicians with psychedelic clinical-trial experience.
• Commercialization Post-Launch Services Post-launch support services helping drug developers roll out approved psychedelic treatments, including clinician training, clinic-staff training, patient education materials, and off-label application training programs.

Quantifiable outcome

• 8,000+ therapists trained and certified
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Reunion NeurosciencecoreStrategic or Co-development PartnerStrategic partnership integrating Fluence's AI-powered training tool into Reunion Neuroscience's clinical trials. Reunion is committed to leveraging cutting-edge technologies to enhance the quality and scalability of psychedelic therapy training.
• CybincoreStrategic or Co-development PartnerPartnership with Cybin to integrate Fluence's AI-powered training platform for provider development. Alex Kelman, Ph.D., Head of Therapies at Cybin, noted Fluence's leadership in psychedelic therapy education and technology-based competency development.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• MAPS Public Benefit Corporation: The leading nonprofit/benefit organization developing MDMA-assisted therapy; directly comparable because it has built standardized therapist training programs and treatment manuals for clinical trials that overlap directly with Fluence's psychedelic therapy curriculum.
• Sage Institute: Psychedelic therapy training organization offering clinician certification programs; closely comparable to Fluence in delivering accredited training for ketamine- and psilocybin-assisted therapy practice.
• Synthesis Institute: Psychedelic facilitator and therapist training provider offering certificate programs; comparable to Fluence in curriculum structure, clinician audience, and psychedelic-therapy emphasis.
• Psychedelic.Support: Discovery platform and education provider for psychedelic therapists; comparable to Fluence for its therapist directory and clinician education offerings that compete for the same B2C audience of trained therapists.
• InnerTrek: Oregon-approved psilocybin facilitator training program that prepares clinicians for state-licensed practice; comparable to Fluence as a direct provider of state/pathway-licensed psychedelic facilitator certification.
• Changa Institute: Psychedelic education and facilitator training provider; comparable to Fluence for its curriculum programs aimed at clinicians seeking psychedelic facilitation credentials.
• Polaris Insight Center: Ketamine-assisted psychotherapy training center for clinicians; comparable to Fluence because it operates in the same ketamine-assisted psychotherapy training vertical with similar clinician audiences.

Broad incumbents

• Compass Pathways: Public psychedelic drug developer running large psilocybin trials; comparable because it operates (and historically invested in) its own therapist training infrastructure for psilocybin therapy, placing it in direct competition for psychedelic trial training demand.
• Relias: Large healthcare workforce training and compliance platform serving hospitals and behavioral health providers; comparable to Fluence as a scaled, accredited e-learning incumbent that could expand into psychedelic CE content for clinicians.
• HealthStream: Enterprise healthcare workforce development and compliance training platform; comparable to Fluence for its accredited continuing education, regulatory training, and clinical training capabilities targeted at the same clinician buyer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Fluencetraining
• Facebookfacebook.com/FluenceTraining
• LinkedInlinkedin.com/company/fluencetraining

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds3 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluence